
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on March 28, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
7,637 cr
Turnover Ratio
16.09%
Expense Ratio
0.91%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 6.61%
- 1Y: 13.23%
- 3M: -7.25%
- 3Y: 19.76%
- 6M: -7.74%
- 5Y: 29.58%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
469.851 | 21.25% | 3,313 cr | 0.97% | - | ||
38.900 | 20.88% | 4,611 cr | 1.11% | - |
Other plans of Nippon India Pharma